top of page
image (25).png

Our Sponsors

Platinum Sponsor

Valence Logo.png

Valence is harnessing a revolution in computation to improve human health.

Valence is committed to unlocking the true potential of deep learning in drug design. By combining novel computational technologies with intuitive infrastructure to enable integration into R&D organizations of all sizes, Valence is empowering drug discovery scientists everywhere with the tools they need to design better drug candidates, faster. 

Gold Sponsor

We believe our Intelligence Processing Unit (IPU) technology will become the worldwide standard for machine intelligence compute. The Graphcore IPU is going to be transformative across all industries and sectors with a real potential for positive societal impact from drug discovery and disaster recovery to decarbonization. The IPU is a completely new processor, specifically designed for AI compute. The IPU’s unique architecture lets AI researchers undertake entirely new types of work, not possible using current technologies, to drive the next advances in machine intelligence.

Silver Sponsor


Ventus Therapeutics is a biopharmaceutical company deploying leading-edge structural biology and computational chemistry tools to create novel small molecule medicines for challenging targets, with an initial focus on immunology, inflammation, and neurology. The Company’s proprietary drug discovery platform, ReSOLVETM, gives it the ability to discover and develop medicines through unique insights into protein targets and to create dynamic blueprints that can guide the development of differentiated therapies at a fast pace. Ventus’ first target screen was conducted in 2020, which led to the nomination of three development candidates in 2022, including: VENT-03, a potential first-in-class cGAS inhibitor; VENT-02, a brain-penetrant NLRP3 inhibitor; and VENT-01, a peripherally restricted NLRP3 inhibitor. These programs exemplify Ventus’ unique discovery capabilities and focus on first- and best-in-class programs for multi-indication immunology targets with franchise potential.  

Bronze Sponsors


Deeply rooted in Montreal and dedicated to its international mission, Université de Montréal is a leading research university.


With its affiliated schools, Polytechnique Montréal and HEC Montréal, UdeM is Quebec’s biggest university complex and one of the largest in North America. Among French-language universities it ranks 6th, and among all universities 111th, according to Times Higher Education, placing it in the first percentile of the world’s top institutions of higher learning.


UdeM attracts over $500 million in research funding every year, making it one of Canada’s top university research hubs. UdeM is home to 145 Canada Research Chairs, 2 Canada Excellence Research Chair and one Canada 150 Research Chair, allocated to the preeminent scholars in their fields. Many renowned research institutes and centres are affiliated to UdeM, including: Mila, the world's leading research centre for artificial intelligence, IVADO and the Institute for Research in Immunology and Cancer (IRIC), one of the most dynamic in its field.


Montréalaise par ses racines, internationale par vocation, l’Université de Montréal compte parmi les plus grandes universités de recherche.


L’UdeM forme avec ses écoles affiliées, Polytechnique Montréal et HEC Montréal, le premier complexe universitaire du Québec et l’un des plus importants en Amérique. Au 111e rang international et au 6e rang du monde francophone selon le classement du Times Higher Education, elle figure dans le premier percentile des meilleures universités.


Chaque année, l’Université récolte plus d’un demi-milliard de dollars en fonds de recherche, ce qui la situe parmi les premiers pôles de recherche universitaire canadiens. L’UdeM abrite 145 chaires de recherche du Canada, 2 chaires d’excellence en recherche du Canada et 1 chaire de recherche Canada 150, qui sont attribuées aux meilleurs spécialistes dans leur domaine. De nombreux instituts et centres de recherche de renom sont affiliés à l’UdeM, comme Mila ‒ premier centre universitaire en intelligence artificielle dans le monde ‒, IVADO et l’Institut de recherche en immunologie et en cancérologie (IRIC) ‒ l’un des plus dynamiques dans son domaine.

bottom of page